Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference18 articles.
1. Expert panel report 3: guidelines for the diagnosis and management of asthma—Full report;National Asthma Education and Prevention Program,2007
2. Nonadherence in asthmatic patients: is there a solution to the problem?;Bender;Ann Allergy Asthma Immunol,1997
3. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies;Stoloff;J Allergy Clin Immunol,2004
4. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol fluticasone in moderate to severe asthma;Aalbers;Curr Med Res Opin,2004
5. EXCEL: a randomized trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma;Dahl;Respir Med,2006
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Differences in the effectiveness of single, dual, and triple inhaled corticosteroid therapy for reducing future risk of severe asthma exacerbation: A systematic review and network meta-analysis;Heliyon;2024-06
2. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23
3. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-08-21
4. Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-12-06
5. May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?;Pulmonary Pharmacology & Therapeutics;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3